Tue, Aug 06, 2024
At 11.18 AM, BSE Sensex was 0.79 per cent or 635.22 points up at 79,394.62 while Nifty 50 was 0.78 per cent or 186.5 points higher at 24,242.10.
More >
Tue, Mar 28, 2023
After these two approvals, Zydus has a total of 355 approvals and has so far filed over 440 ANDAs (as of 31 December 2022). The company started the filing process in FY 2003-04.
Mon, Feb 20, 2023
Zydus Lifesciences said it has received tentative approvals from the US health regulator to market two generic drugs.
Mon, Aug 01, 2022
Pharmaceutical companies’ stocks such as Cipla, Zydus Wellness, and Torrent Pharma rose up to 5% on the BSE intraday trade.
Despite healthy Q1FY23 earnings, the pharma major Sun Pharma shares were seen trading flat in the early morning and later declined more than 3 per cent to Rs 913 per share on the BSE intraday on Monday.
Tue, May 11, 2021
Sharekhan says that Zydus Wellness revenue grew by 24.2% yoy to Rs 606 cr in Q4FY2021, better than our expectation of Rs 537.5 cr. Except for Nutralite and Glucon D, all other brands registered high double-digit revenue growth during the quarter. Late start to season resulted in high single digit growth for Glucon D, while Nutralite sales (largely an institutional business) saw sequential improvement in sales, which reached pre-COVID levels in Q4. Despite firm palm oil prices, benign dairy prices and better revenue mix led to 71 bps improvements in the gross margins
Wed, Jul 31, 2019
Stock market experts are of the opinion that Kotak Mahindra Bank and Zydus Wellness stocks are poised to give an upside momentum in coming few trade hours and advises to buy with given handles in thier BTSTT stock category.
Wed, Dec 12, 2018
Shares of Zydus Wellness surged over 4 per cent Wednesday as the CCI approved Zydus Cadila's deal to acquire Heinz India's consumer wellness business.
Thu, Oct 25, 2018
Kraft Heinz has proposed to carve out business related to ketchup, tomato sauce, mayonnaise, before the closing of the transaction. Post announcement, shares of Zydus Wellness closed 4.29% lower at Rs 1203.95 per scrip on BSE while shares of Cadila Healthcare closed 5.17% lower at Rs 358.40 on BSE on Wednesday.
Wed, Oct 24, 2018
The deal with Ahmedabad-based Zydus, which is a unit of Cadila Healthcare Ltd, could be announced as early as this week, the report said, adding that Zydus has been discussing a value of about 46 billion rupees ($625 million) for the businesses.
Fri, Aug 03, 2018
Shares of Zydus Wellness today closed at Rs 1,502.35 per scrip on BSE, up steep 5.10 per cent from its previous close.
Thu, May 12, 2016
The stock of the company traded up 12.60% to Rs 848.8 during the day on the Bombay Stock Exchange (BSE).
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
